Physician profile
Christopher C Seip
NPI 1023011897
$6,354.77
in general payments reported to CMS, 2019-2025
10 companies · $5,567 in 2025
The $5,567 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.83 · 2020: $173 · 2021: $96.93 · 2022: $38.54 · 2023: $61.75 · 2024: $348 · 2025: $5,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,026 · Travel and Lodging: $1,677 · Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,025.70 |
| Travel and Lodging | $1,677.11 |
| Food and Beverage | $273.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,721.35 | 2024-2025 | |
| Ethicon US, LLC | $195.53 | 2020-2024 | Echelon Flex, Linx Reflux Management System, Harmonic |
| Smith+Nephew, INC. | $161.87 | 2019-2023 | Grafix Pl |
| Merck Sharp & Dohme LLC | $66.64 | 2025 | Bridion |
| Organogenesis INC. | $64.95 | 2020-2024 | |
| Davol INC. | $63.30 | 2020 | |
| Integra Lifesciences Corporation | $24.04 | 2022 | |
| Osiris Therapeutics INC. | $23.86 | 2019 | |
| Polynovo North America LLC | $18.73 | 2025 | Novosorb Btm |
| Hologic INC | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Seip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.